GLP-1s and their successors for type 2 diabetes, cardiovascular disease, and addiction (to counter Western disease from diet) and vaccines and immunotherapy for cancers (many cancers appear to be caused by viruses [1]). How you incentivize the scaled production of “healthy” foods in this macro seems intractable unfortunately, but patching reward centers around food macro and quantity consumption and cancer prevention via vaccines takes us a long way [2] [3].

Eli Lilly is seeking FDA approval for orforglipron, a once daily pill that is as effective, safe and tolerable to take as injectable semaglutide [4]. "Just think about the idea of having a pill that can be distributed anywhere in the world, that doesn't need to be refrigerated," Aronne told CBS News. "It's as effective as one of the injectable drugs we have now: Semaglutide. That is a big deal."

[1] https://www.cancer.org/cancer/risk-prevention/infections/inf...

[2] https://www.cdc.gov/chronic-disease/data-research/facts-stat...

[3] https://www.cms.gov/data-research/statistics-trends-and-repo...

[4] https://www.cbsnews.com/news/eli-lilly-glp-1-pill-trial-fda-...